FDWM
Fidelity Covington Trust - Fidelity Women`s Leadership ETF

1
Loading...
Loading...
News
all
press releases
News Placeholder
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate.
Stocktwits·1mo ago
News Placeholder
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence
FDA reviewers said in briefing documents that the benefit-risk profile of the drug for the treatment of multiple myeloma “remains unclear.”
Stocktwits·2mo ago
News Placeholder
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance
A decision by the FDA on the new submission is expected in the first half of 2026.
Stocktwits·2mo ago

Latest FDWM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.